Stephanie Duatschek

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

Biomet, Inc. engages in the design, manufacture, and market of musculoskeletal therapy products. The company was founded by Dane A. Miller, Niles L. Noblitt, Jerry L. Ferguson and M. Ray Harroff on November 30, 1977 and is headquartered in Warsaw, IN.

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.

Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY.

N-Gene Research Laboratories, Inc. operates as a clinical stage biopharmaceutical firm which focuses on developing a series of synthetic small molecules having a therapeutic effect via stress response modulation. Its products include oral anti-diabetic, skincare, and prokynetic. The company was founded by Peter Literati-Nagy in 1997 and is headquartered in New York, NY.

Medline Industries, Inc. engages in the manufacture and distribution of healthcare supplies. Its products include advanced wound care, apparel, diagnostics, gloves, nutrition, office supplies, respiratory, and vascular access. The firm also offer quality management, reducing readmissions, staff management, capital planning and services, and institute for healthcare excellence business solutions. The company was founded by A. J. Mills in 1910 and is headquartered in Mundelein, IL.

Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ.

Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA.

DynPort Vaccine Co. LLC develops vaccines, biologic products and small molecule anti-infectives. It provides its products and services to the defense and military sectors in the United States. The company was founded in 1997 by Zsolt Pál Harsányi and is headquartered in Reston, VA.

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC.

The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD.

North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC.

The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012.

Part of Barclays PLC, E.F. Hutton & Co., Inc. is a company that provides investment and financial services. The company is based in Providence, RI.

Water Street Healthcare Partners LLC (Water Street Healthcare Partners) is a private equity firm founded in 2005. The firm is headquartered in Chicago, Illinois.

SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.

Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation.

OptiFilter Research Zrt. manufactures cigarette filters. The firm offers diagnostic examination for cancer screening, human papillomavirus test and an epigenetic biomarker, and laboratory analysis. The company was founded on November 26, 2014 and is headquartered in Pécs, Hungary.

Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands.

Beyeonics Surgical Ltd. is a medical technology company based in Haifa, Israel. The Israeli company, along with its sister company Beyeonics Vision, develops and delivers digital surgical platforms to operating rooms across multiple therapeutic areas. Beyeonics Surgical focuses on orthopedic surgical platforms and has pipeline applications that include minimally invasive surgery utilizing VR and AR-based navigation and data processing. The company was founded by Avi Zeitouny and Ron Schneider, with Ron Schneider serving as CEO since incorporation.

Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler.